Sarepta Therapeutics said Tuesday that it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

An Amgen obesity drug helped participants lose a substantial amount of weight, but questions about how competitive it could ...

Will the Novo-Catalent merger be challenged under the new Trump administration? A former FTC policy director thinks so.

What’s more, the rise of technology in medicine, while beneficial in many ways, has further reduced the use of empathic touch ...

A cancer treatment from Roche failed to improve survival in a major lung cancer study, a result that will stoke doubts about ...

The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These ...

Former HHS Secretary Tom Price writes that the new Trump administration should update immigration laws to help the U.S.

The presumptive new CDC director, Dave Weldon, is a known vaccine safety skeptic. In contrast, the FDA choice — Johns Hopkins ...

Alector Therapeutics, working with AbbVie, was testing whether modulating immune cells in brain would slow Alzheimer's ...

First-of-its-kind data analysis finds UnitedHealth Group pays many of its own physician practices significantly more than the ...

Minnesota has becomes the first state to release a report examining the 340B drug discount program for "safety-net" hospitals ...